Skip to content
ClinCalc Pro
Menu
NSAID — Renal / Ureteric Colic

Diclofenac

Brand names: Voltarol, Dyloject (IV)

Diclofenac is a non-steroidal anti-inflammatory drug; in urology it is widely used for the acute pain of renal or ureteric colic, where NSAIDs are first-line analgesia. It is available by oral, rectal, and parenteral routes.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits cyclo-oxygenase (COX-1 and COX-2), reducing prostaglandin synthesis, which relieves pain and, in ureteric colic, lowers intraureteric pressure and renal pelvic pressure.

Prescribing in practice

  • Avoid in significant renal impairment, hypovolaemia, or dehydration because NSAIDs can precipitate acute kidney injury in the obstructed or volume-depleted patient.
  • It carries gastrointestinal bleeding and cardiovascular thrombotic risks and is contraindicated in established cardiovascular disease, so use the lowest effective course.
  • Use with caution alongside anticoagulants, other NSAIDs, and drugs affecting renal perfusion per the SPC.

Monitoring

Monitor renal function and blood pressure with repeated or prolonged use and remain alert to gastrointestinal symptoms.

Counselling the patient

  • Take with or after food to reduce stomach upset.
  • Report black stools, vomiting blood, or significant indigestion promptly.
  • Use for the shortest time needed to control colic pain.

Evidence & guidelines

Recommended as first-line analgesia for renal colic on the basis of trials showing NSAIDs provide effective pain relief with less need for rescue analgesia than opioids.

Reference: RCEM Clinical Standards for Emergency Analgesia; EAU Urolithiasis Guidelines 2024; MHRA 2013; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.